Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

49.84 -0.62 (-1.23%)
Streaming Delayed Price Updated: 11:39 AM EDT, Jul 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
The 7 Best Biotech Stocks for Personalized Medicine Investors
Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics. 
Via InvestorPlace
Cathie Wood’s Next Big Bet: 3 Disruptive Innovations to Watch
These Cathie Wood stocks could deliver massive gains in the coming years as they disrupt traditional industries. 
Via InvestorPlace
What Has Cathie Wood Been Trading?
The story of Ark Invest, Wall Street veteran Cathie Wood’s lineup of actively managed, innovation-centric ETFs is well-known at this point. Ark has been defined by big bets, big wins, big losses, and... 
Via Benzinga
2 Supercharged Growth Stocks That Could Rocket 116% to 899% Higher, According to Wall Street
Find out why expectations are so high for these two innovative businesses. 
Via The Motley Fool
The 3 Best Millionaire-Maker Stocks to Buy for April 2023
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire. 
Via InvestorPlace
Analyst Ratings for Exact Sciences
Via Benzinga
Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know
Via Benzinga
Earnings Preview For Exact Sciences
Via Benzinga
The Latest Analyst Ratings for Exact Sciences
Via Benzinga
3 Cathie Wood Stocks for Your April Must-Buy List
Cathie Wood stocks are doing much better in 2023 than last year. Here are three to put on your April must-buy list. 
Via InvestorPlace
FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle
The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell. 
Via Investor's Business Daily
3 Stocks With Superior Potential for Super-Sized Gains in 2023
Investing in stocks with potential is a great way to make money as long as you do your research and understand the risks involved. 
Via InvestorPlace
If You Invested $10,000 in Exact Sciences in 2018, This Is How Much You Would Have Today
Has this been a market-beating investment? 
Via The Motley Fool
EXAS Stock Is a Hidden Gem in the Healthcare Sector for Bold Investors
Patient investors who have room for an intriguing medical-niche investment in their portfolio should take a closer look at EXAS stock. 
Via InvestorPlace
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
Meta Platforms To Rally Over 36%? Here Are 10 Other Analyst Forecasts For Wednesday
Credit Suisse cut the price target for Zscaler, Inc. (NASDAQ: ZS) from $275 to $165. Credit Suisse analyst Sami Badri maintained an Outperform rating. Zscaler shares fell 1.9% to $105.95 in pre-market... 
Via Benzinga
7 Growth Stocks Sitting in a Sweet Spot
Offering ample growth potential, and each attractively-priced, now's the time to buy these seven growth stocks. 
Via InvestorPlace
A Nasdaq Bull Market Is Coming: 2 Revolutionary Stocks to Buy and Hold
It pays to be an innovator. 
Via The Motley Fool
What You Missed On Wall Street On Thursday
SVB Financial is lower after the company announced it was undertaking a strategic repositioning of its balance sheet and also provided a negative update to both Q1 and full-year 2023 guidance. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
Via Benzinga
Cathie Wood Is Betting Big on These 5 AI Stocks
Investors are betting on Cathie Wood again thanks to growing AI stocks interest. Wood's Ark Invest holds several compelling AI picks. 
Via InvestorPlace
Exact Sciences (EXAS) Q4 2022 Earnings Call Transcript
EXAS earnings call for the period ending December 31, 2022. 
Via The Motley Fool
After-Hours Action: What's Going On With Exact Sciences Stock?
Exact Sciences Corp (NASDAQ: EXAS) shares are facing selling pressure after the close on Tuesday on the heels of the company's quarterly results. 
Via Benzinga
Exact Sciences, Which Outperforms 95% Of All Stocks, Just Beat Quarterly Estimates
Exact Sciences is leaned on Cologuard for strong fourth-quarter sales growth. 
Via Investor's Business Daily
Cathie Wood Bulks Up On Shopify Amid Stock's 18% Post-Earnings Drop, Sells This Major Holding Up 30% This Week
Cathie Wood’s Ark Invest reversed its stance on Canadian e-commerce retailer Shopify, Inc. (NYSE: SHOP) and began bulking up on the stock this week. 
Via Benzinga
25 AI Stocks to Buy Right Now
Looking to benefit from the AI boom started by ChatGPT? Here are the best AI stocks to buy for the emerging market frenzy. 
Via InvestorPlace
Is Exact Sciences or Editas Medicine the Better Growth Stock to Own in 2023?
Which of these rebounding biotech stocks is the better buy right now? 
Via The Motley Fool
3 Growth Stocks That Are Off to Hot Starts in 2023
Are these stocks still good buys right now? 
Via The Motley Fool
7 AI Penny Stocks to Watch as a New Bull Market Emerges
Looking to profit off the current AI boom? Here are the most important AI penny stocks for investors to be watching. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2023
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.